The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies,
Business Model:
Revenue: $500M
Employees: 51-200
Address: 270 Peachtree Street NW
City: Atlanta
State: GA
Zip: 30303
Country: US
The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies, create high-value jobs and transform lives. Since its formation in 1990, GRA has leveraged over $600 million of state funding into: $2.6 billion of direct federal and private investment in Georgia 150+ newly launched companies 6,000+ high-skill, high-value jobs a portfolio of inventions, processes and technologies that benefit humankind GRA is an independent nonprofit (501c3) organization closely aligned with Georgia’s Department of Economic Development and works with the following partner universities: University of Georgia, Georgia Regents University, Emory University, Clark Atlanta University, Georgia Institute of Technology, Georgia State University, Mercer University and Morehouse School of Medicine.
Contact Phone:
+14043329770
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2009 | Inhibikase Therapeutics | Grant | 50k |
6/2017 | BioPace | Grant | 30.3k |
3/2019 | Abby Med | Grant | 50.6k |
2/2019 | Cognition Medical | Grant | 66k |
1/2016 | Corami Therapeutics | Grant | 58.2k |
10/2014 | Abby Med | Grant | 110k |
7/2016 | RePredix | Grant | 44k |
11/2008 | Inhibikase Therapeutics | Grant | 55.6k |
1/2019 | Neovaccine Strategies | Grant | 50k |
1/2011 | Whisper Communications | Grant | 48k |
4/2012 | Cambium Medical Technologies | Grant | 25k |
11/2010 | NeurOp | Grant | 150k |
9/2013 | QUE Oncology | Grant | 119k |
2/2013 | QUE Oncology | Grant | 25k |
10/2012 | QUE Oncology | Grant | 25k |
7/2014 | QUE Oncology | Grant | 98.9k |
5/2017 | Nutrivert | Grant | 23.8k |
1/2018 | Centizyme | Grant | 35.2k |
5/2014 | NovAb | Grant | 50k |
12/2012 | NovAb | Grant | 25k |
3/2005 | NeurOp | Grant | 50k |
10/2011 | NeurOp | Grant | 100k |
9/2017 | NatGlycan | Grant | 25k |
11/2015 | TendoNova | Grant | 49.3k |
8/2017 | TendoNova | Grant | 43.6k |
3/2019 | TendoNova | Grant | 36k |
3/2019 | Sequegenics | Grant | 32.5k |
7/2014 | CloudTags | Grant | 15k |
5/2014 | Cambium Medical Technologies | Grant | 60k |
7/2007 | Velocity Medical Solutions | Grant | 100k |
1/2007 | Velocity Medical Solutions | Grant | 50k |
12/2005 | Velocity Medical Solutions | Grant | 50k |
10/2017 | Abby Med | Grant | 40.6k |
4/2015 | LymphaTech | Seed Round | - |
7/2016 | MoQuality | Grant | 275k |
10/2011 | Cambium Medical Technologies | Grant | 25k |
4/2016 | Nyra Medical | Grant | 20k |
4/2009 | NeurOp | Grant | 50k |
1/2012 | AKESOgen | Grant | 150k |
9/2013 | Behavioral Science Technologies | Grant | 22.8k |
10/2011 | Nyra Medical | Grant | 10k |
12/2014 | NovAb | Grant | 150k |
4/2012 | NovAb | Grant | 25k |
3/2018 | RePredix | Grant | 36k |
3/2020 | Aviabiotic | Grant | 0 |
8/2005 | NeurOp | Grant | 50k |
8/2018 | Centizyme | Grant | 10k |
3/2017 | Urjanet | Series C | 0 |
3/2017 | DIASYST Inc. | Grant | 50k |
3/2014 | Sanguina | Grant | 25k |
2/2019 | Lucid Scientific | Grant | 26.4k |
4/2016 | NovAb | Grant | 100k |
5/2018 | PDx Scan | Grant | 17.5k |
5/2017 | Sanguina | Grant | 61k |
2/2013 | Sanguina | Grant | 13k |
7/2014 | Nyra Medical | Grant | 52.3k |
2/2011 | AKESOgen | Grant | 50k |
10/2011 | AKESOgen | Grant | 100k |
9/2014 | AlphaStem | Grant | 82.7k |
7/2012 | AlphaStem | Grant | 4k |
3/2016 | DIASYST Inc. | Grant | 50k |
12/2016 | Covanos | Grant | 49.9k |
1/2015 | CloudTags | Grant | 75k |
11/2022 | Nyra Medical | Series A | 20M |
10/2009 | Inhibikase Therapeutics | Grant | 50k |
8/2019 | HAWA Therapeutics | Seed Round | 25k |
12/2006 | Velocity Medical Solutions | Grant | 25k |
11/2018 | Antios Therapeutics | Series A | 0 |
11/2022 | Nyra Medical | Series A | 0 |
9/2014 | Clearside Biomedical | Series B | 16M |
8/2019 | Pyrefin | Grant | 52.6k |
11/2017 | Centizyme | Grant | 10k |
2/2017 | Sophia Bioscience | Grant | 59.2k |
7/2017 | RePredix | Grant | 25k |
8/2019 | Proxime | Grant | 40.1k |
4/2018 | BioPace | Grant | 54.5k |
2/2018 | Proxime | Grant | 27k |
3/2014 | AngioCloud | Grant | 54.4k |
2/2019 | Aviabiotic | Grant | 30k |
11/2019 | PNP Therapeutics | Grant | 50k |
11/2011 | Metaclipse Therapeutics | Grant | 25k |
4/2019 | Oncospherix | Grant | 41.6k |
1/2012 | Nyra Medical | Grant | 25k |
3/2020 | Neovaccine Strategies | Grant | 0 |
1/2019 | Migra Therapeutics | Grant | 51.7k |
2/2020 | Focused Cryo | Grant | 0 |
9/2016 | Nyra Medical | Grant | 74.9k |
1/2020 | Nyra Medical | Grant | 0 |
2/2018 | Oncospherix | Grant | 22.4k |
2/2020 | Focused Cryo | Grant | 0 |
7/2017 | NanoV Therapeutics | Grant | 24.8k |
7/2010 | Inhibikase Therapeutics | Grant | 150k |
9/2008 | Inhibikase Therapeutics | Grant | 25k |
8/2016 | CellectCell | Grant | - |
10/2015 | CellectCell | Grant | - |
11/2008 | Inhibikase Therapeutics | Grant | 25k |
12/2019 | Focused Cryo | Grant | 0 |
11/2017 | Covanos | Grant | 39k |
12/2015 | Covanos | Grant | 80.5k |
3/2018 | Covanos | Grant | 40k |
5/2014 | MicroBplex | Grant | 73k |
9/2014 | RSV NewCo | Grant | 50k |
6/2016 | MicroBplex | Grant | 100k |
2/2018 | Cognition Medical | Grant | 84k |
11/2015 | Accuitis | Seed Round | 0 |
7/2012 | MicroBplex | Grant | 25k |
7/2018 | BioPace | Grant | 105.2k |
3/2014 | Abby Med | Grant | 34k |
7/2010 | Iconic Therapeutics | Grant | 100k |
3/2018 | Migra Therapeutics | Grant | 35.8k |
9/2017 | MicroBplex | Grant | 50.7k |
12/2016 | Neurotrack | Grant | 800k |
3/2016 | Sequegenics | Grant | 47.5k |
1/2016 | Codoxo | Grant | 0 |
4/2010 | Iconic Therapeutics | Grant | 150k |
7/2012 | Sanguina | Grant | 25k |
1/2010 | Iconic Therapeutics | Grant | 50k |
4/2017 | Corami Therapeutics | Grant | 29.9k |
7/2019 | Kodikaz Therapeutic Solutions | Grant | 50k |
5/2015 | Corami Therapeutics | Grant | 11.8k |
10/2017 | Corami Therapeutics | Grant | 41.9k |
9/2011 | Inhibikase Therapeutics | Grant | 100k |
1/2020 | BioData Consortium | Grant | 20k |
7/2019 | BioData Consortium | Grant | 25k |
3/2017 | Sequegenics | Grant | 65k |
9/2006 | Velocity Medical Solutions | Grant | 50k |
8/2009 | Iconic Therapeutics | Grant | 48k |
3/2016 | Sanguina | Grant | 81k |
7/2019 | Lucid Scientific | Grant | 58.5k |
9/2017 | Reservoir | Grant | 25k |
7/2015 | QUE Oncology | Grant | 150k |
11/2015 | QUE Oncology | Grant | 100k |
1/2011 | AKESOgen | Grant | 50k |
6/2018 | Lucid Scientific | Grant | 23.9k |
12/2016 | NatGlycan | Grant | 25k |
6/2016 | DIASYST Inc. | Grant | 50k |
7/2012 | Metaclipse Therapeutics | Grant | 57.5k |
4/2012 | Metaclipse Therapeutics | Grant | 42k |
11/2010 | Metaclipse Therapeutics | Grant | 25k |
8/2021 | TendoNova | Seed Round | 250k |
6/2017 | Covanos | Grant | 75k |
3/2020 | AngioCloud | Grant | 34.3k |
2/2022 | EarliTec Diagnostics | Series A | 19.5M |
6/2011 | LiquidText | Grant | - |
9/2006 | NeurOp | Grant | 25k |
1/2019 | DIASYST Inc. | Grant | 50k |
9/2019 | TendoNova | Grant | 69k |
1/2019 | MapHabit | Grant | 48.4k |
10/2018 | MapHabit | Grant | 58.5k |
12/2008 | Velocity Medical Solutions | Grant | 150k |
11/2013 | MedShape | Seed Round | - |
5/2015 | MetCure Therapeutics | Grant | - |
2/2019 | Pyrefin | Grant | 48.1k |
6/2018 | Oncospherix | Grant | 53.4k |
7/2018 | PNP Therapeutics | Grant | 50k |
1/2018 | Celtaxsys | Series E | - |
2/2022 | EarliTec Diagnostics | Series A | 0 |
3/2020 | Aviabiotic | Grant | 0 |
3/2020 | AngioCloud | Grant | 0 |
3/2020 | Neovaccine Strategies | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
1/2020 | Nyra Medical | Grant | 0 |
1/2020 | BioData Consortium | Grant | 0 |
12/2019 | Focused Cryo | Grant | 0 |
11/2019 | PNP Therapeutics | Grant | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|